{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:14:34Z","timestamp":1763554474476,"version":"3.45.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089"],"award-info":[{"award-number":["RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089","RS-2023-00220089"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24452-3","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:11:04Z","timestamp":1763554264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting dual-specificity phosphatase 23 to overcome chemoresistance and stem cell-like behavior in non-small cell lung cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Seula","family":"Keum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongeun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jangho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye Eun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Hye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangmyung","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24452_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"24452_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D. et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243\u20131260. https:\/\/doi.org\/10.1097\/JTO.0000000000000630 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"24452_CR3","doi-asserted-by":"publisher","first-page":"170070","DOI":"10.1098\/rsob.170070","volume":"7","author":"S Blandin Knight","year":"2017","unstructured":"Blandin Knight, S. et al. Progress and prospects of early detection in lung cancer. Open Biol. 7, 170070. https:\/\/doi.org\/10.1098\/rsob.170070 (2017).","journal-title":"Open Biol."},{"key":"24452_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.addr.2018.08.012","volume":"133","author":"WH Lee","year":"2018","unstructured":"Lee, W. H. et al. The potential to treat lung cancer via inhalation of repurposed drugs. Adv. Drug Deliv. Rev. 133, 107\u2013130. https:\/\/doi.org\/10.1016\/j.addr.2018.08.012 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"24452_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Li, Y., Wang, Z., Ajani, J. A. & Song, S. Drug resistance and cancer stem cells. Cell Commun. Signal 19, 19. https:\/\/doi.org\/10.1186\/s12964-020-00627-5 (2021).","journal-title":"Cell Commun. Signal"},{"key":"24452_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh, J. J. & Ma, S. Hallmarks of cancer stemness. Cell Stem Cell 31, 617\u2013639. https:\/\/doi.org\/10.1016\/j.stem.2024.04.004 (2024).","journal-title":"Cell Stem Cell"},{"key":"24452_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert, A. W. & Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer 21, 325\u2013338. https:\/\/doi.org\/10.1038\/s41568-021-00332-6 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"24452_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cas.14285","volume":"111","author":"Q Quan","year":"2020","unstructured":"Quan, Q. et al. Cancer stem-like cells with hybrid epithelial\/mesenchymal phenotype leading the collective invasion. Cancer Sci. 111, 467\u2013476. https:\/\/doi.org\/10.1111\/cas.14285 (2020).","journal-title":"Cancer Sci."},{"key":"24452_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald, L. B., Bellet, D. & Dangles-Marie, V. Spherical cancer models in tumor biology. Neoplasia 17, 1\u201315. https:\/\/doi.org\/10.1016\/j.neo.2014.12.004 (2015).","journal-title":"Neoplasia"},{"key":"24452_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/bj20082234","volume":"418","author":"KI Patterson","year":"2009","unstructured":"Patterson, K. I., Brummer, T., O\u2019Brien, P. M. & Daly, R. J. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418, 475\u2013489. https:\/\/doi.org\/10.1042\/bj20082234 (2009).","journal-title":"Biochem. J."},{"key":"24452_CR11","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.biocel.2003.12.014","volume":"36","author":"Q Wu","year":"2004","unstructured":"Wu, Q. et al. Molecular cloning and characterization of a novel dual-specificity phosphatase 23 gene from human fetal brain. Int. J. Biochem. Cell Biol. 36, 1542\u20131553. https:\/\/doi.org\/10.1016\/j.biocel.2003.12.014 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"24452_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20040498","volume":"383","author":"K Takagaki","year":"2004","unstructured":"Takagaki, K. et al. Characterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38. Biochem. J. 383, 447\u2013455. https:\/\/doi.org\/10.1042\/BJ20040498 (2004).","journal-title":"Biochem. J."},{"key":"24452_CR13","doi-asserted-by":"publisher","first-page":"27114","DOI":"10.1038\/srep27114","volume":"6","author":"LL Gallegos","year":"2016","unstructured":"Gallegos, L. L. et al. A protein interaction map for cell-cell adhesion regulators identifies DUSP23 as a novel phosphatase for beta-catenin. Sci. Rep. 6, 27114. https:\/\/doi.org\/10.1038\/srep27114 (2016).","journal-title":"Sci. Rep."},{"key":"24452_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bbrc.2018.04.205","volume":"500","author":"J Jeong","year":"2018","unstructured":"Jeong, J. et al. Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation. Biochem. Biophys. Res. Commun. 500, 937\u2013943. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.205 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"24452_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-024-01604-9","author":"S Keum","year":"2024","unstructured":"Keum, S., Lee, Y. J., Kim, J. W. & Rhee, S. Dual-specificity phosphatase 23 functions as a promising prognostic biomarker in non-small cell lung cancer. Genes Genomics https:\/\/doi.org\/10.1007\/s13258-024-01604-9 (2024).","journal-title":"Genes Genomics"},{"key":"24452_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13578-023-01061-z","volume":"13","author":"Q Sui","year":"2023","unstructured":"Sui, Q. et al. The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data. Cell Biosci. 13, 103. https:\/\/doi.org\/10.1186\/s13578-023-01061-z (2023).","journal-title":"Cell Biosci."},{"key":"24452_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/JBM.S437400","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu, X., Zhuang, H., Li, F., Lu, Y. & Pei, R. Prognostic significance of dual-specificity phosphatase 23 expression in acute myeloid leukemia. J Blood Med. 15, 35\u201350. https:\/\/doi.org\/10.2147\/JBM.S437400 (2024).","journal-title":"J Blood Med."},{"key":"24452_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1476-4598-9-128","volume":"9","author":"JP Tang","year":"2010","unstructured":"Tang, J. P. et al. VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers. Mol. Cancer 9, 128. https:\/\/doi.org\/10.1186\/1476-4598-9-128 (2010).","journal-title":"Mol. Cancer"},{"key":"24452_CR19","doi-asserted-by":"publisher","first-page":"113860","DOI":"10.1016\/j.biopha.2022.113860","volume":"156","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei, S. et al. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response. Biomed. Pharmacother. 156, 113860. https:\/\/doi.org\/10.1016\/j.biopha.2022.113860 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"24452_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/scd.2008.0055","volume":"18","author":"J Douville","year":"2009","unstructured":"Douville, J., Beaulieu, R. & Balicki, D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev. 18, 17\u201325. https:\/\/doi.org\/10.1089\/scd.2008.0055 (2009).","journal-title":"Stem Cells Dev."},{"key":"24452_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12015-010-9208-4","volume":"7","author":"I Ma","year":"2011","unstructured":"Ma, I. & Allan, A. L. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. Rep. 7, 292\u2013306. https:\/\/doi.org\/10.1007\/s12015-010-9208-4 (2011).","journal-title":"Stem Cell Rev. Rep."},{"key":"24452_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/s0005-2736(99)00167-4","volume":"1461","author":"P Borst","year":"1999","unstructured":"Borst, P., Evers, R., Kool, M. & Wijnholds, J. The multidrug resistance protein family. Biochim. Biophys. Acta 1461, 347\u2013357. https:\/\/doi.org\/10.1016\/s0005-2736(99)00167-4 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"24452_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/cbf.3577","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Zhou, H., Yang, S. & Su, D. Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer. Cell Biochem. Funct. 39, 277\u2013286. https:\/\/doi.org\/10.1002\/cbf.3577 (2021).","journal-title":"Cell Biochem. Funct."},{"key":"24452_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2018.09.017","volume":"132","author":"S Norouzi","year":"2018","unstructured":"Norouzi, S. et al. Crosstalk in cancer resistance and metastasis. Crit. Rev. Oncol. Hematol. 132, 145\u2013153. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.09.017 (2018).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"24452_CR25","doi-asserted-by":"publisher","first-page":"12875","DOI":"10.3390\/ijms232112875","volume":"23","author":"KH Chong","year":"2022","unstructured":"Chong, K. H. et al. Breast cancer with increased drug resistance, invasion ability, and cancer stem cell properties through metabolism reprogramming. Int. J. Mol. Sci. 23, 12875. https:\/\/doi.org\/10.3390\/ijms232112875 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"24452_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1158\/1078-0432.CCR-08-0905","volume":"15","author":"P Laurent-Puig","year":"2009","unstructured":"Laurent-Puig, P., Lievre, A. & Blons, H. Mutations and response to epidermal growth factor receptor inhibitors. Clin. Cancer Res. 15, 1133\u20131139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0905 (2009).","journal-title":"Clin. Cancer Res."},{"key":"24452_CR27","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1038\/s41388-022-02437-0","volume":"41","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer. Oncogene 41, 4307\u20134317. https:\/\/doi.org\/10.1038\/s41388-022-02437-0 (2022).","journal-title":"Oncogene"},{"key":"24452_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7150\/thno.21463","volume":"8","author":"H Zhu","year":"2018","unstructured":"Zhu, H. et al. AKR1C1 activates STAT3 to promote the metastasis of non-small cell lung cancer. Theranostics 8, 676\u2013692. https:\/\/doi.org\/10.7150\/thno.21463 (2018).","journal-title":"Theranostics"},{"key":"24452_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/scd.2007.0098","volume":"17","author":"KM Foshay","year":"2008","unstructured":"Foshay, K. M. & Gallicano, G. I. Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells Dev. 17, 269\u2013278. https:\/\/doi.org\/10.1089\/scd.2007.0098 (2008).","journal-title":"Stem Cells Dev."},{"key":"24452_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman, D. R. & Weinberg, R. A. Tackling the cancer stem cells\u2014What challenges do they pose?. Nat. Rev. Drug Discov. 13, 497\u2013512. https:\/\/doi.org\/10.1038\/nrd4253 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"24452_CR31","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.18632\/oncotarget.6261","volume":"7","author":"CH Lee","year":"2016","unstructured":"Lee, C. H., Yu, C. C., Wang, B. Y. & Chang, W. W. Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs. Oncotarget 7, 1215\u20131226. https:\/\/doi.org\/10.18632\/oncotarget.6261 (2016).","journal-title":"Oncotarget"},{"key":"24452_CR32","first-page":"3487","volume":"10","author":"T Jimenez","year":"2020","unstructured":"Jimenez, T. et al. DUSP9-mediated reduction of pERK1\/2 supports cancer stem cell-like traits and promotes triple negative breast cancer. Am. J. Cancer Res. 10, 3487\u20133506 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"24452_CR33","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/ijc.32965","volume":"147","author":"M Kato","year":"2020","unstructured":"Kato, M. et al. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer. Int. J. Cancer 147, 1987\u20131999. https:\/\/doi.org\/10.1002\/ijc.32965 (2020).","journal-title":"Int. J. Cancer"},{"key":"24452_CR34","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.yexcr.2013.08.023","volume":"319","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7\/ADR breast cancer cells to doxorubicin. Exp. Cell Res. 319, 3140\u20133149. https:\/\/doi.org\/10.1016\/j.yexcr.2013.08.023 (2013).","journal-title":"Exp. Cell Res."},{"key":"24452_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/cr.2007.59","volume":"17","author":"H Qi","year":"2007","unstructured":"Qi, H. & Pei, D. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4. Cell Res. 17, 578\u2013580. https:\/\/doi.org\/10.1038\/cr.2007.59 (2007).","journal-title":"Cell Res."},{"key":"24452_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1476-4598-11-73","volume":"11","author":"S Singh","year":"2012","unstructured":"Singh, S. et al. EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol. Cancer 11, 73. https:\/\/doi.org\/10.1186\/1476-4598-11-73 (2012).","journal-title":"Mol. Cancer"},{"key":"24452_CR37","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/stem.1518","volume":"31","author":"YT Chou","year":"2013","unstructured":"Chou, Y. T. et al. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells 31, 2607\u20132619. https:\/\/doi.org\/10.1002\/stem.1518 (2013).","journal-title":"Stem Cells"},{"key":"24452_CR38","doi-asserted-by":"publisher","first-page":"e06132","DOI":"10.7554\/eLife.06132","volume":"4","author":"SM Rothenberg","year":"2015","unstructured":"Rothenberg, S. M. et al. Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways. Elife 4, e06132. https:\/\/doi.org\/10.7554\/eLife.06132 (2015).","journal-title":"Elife"},{"key":"24452_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41389-020-00292-w","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Feedback activation of STAT3 limits the response to PI3K\/AKT\/mTOR inhibitors in PTEN-deficient cancer cells. Oncogenesis 10, 8. https:\/\/doi.org\/10.1038\/s41389-020-00292-w (2021).","journal-title":"Oncogenesis"},{"key":"24452_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2014.05.019","volume":"26","author":"HJ Lee","year":"2014","unstructured":"Lee, H. J. et al. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. Cancer Cell 26, 207\u2013221. https:\/\/doi.org\/10.1016\/j.ccr.2014.05.019 (2014).","journal-title":"Cancer Cell"},{"key":"24452_CR41","doi-asserted-by":"publisher","first-page":"eaag1796","DOI":"10.1126\/scisignal.aag1796","volume":"10","author":"MJ Chen","year":"2017","unstructured":"Chen, M. J., Dixon, J. E. & Manning, G. Genomics and evolution of protein phosphatases. Sci. Signal 10, eaag1796. https:\/\/doi.org\/10.1126\/scisignal.aag1796 (2017).","journal-title":"Sci. Signal"},{"key":"24452_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24452-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24452-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24452-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:11:05Z","timestamp":1763554265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24452-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24452"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24452-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40770"}}